Thirty-four percentage of PDAC, 17.5% of IHCC, 25% of HCC, 18.2% of CRC, and 12.3% of GEAC tumors had available PD-L1 status by IHC and differences varied by tumor type (Fig. 4B; Supplementary Table S1). The gene discussed is CD274; the disease is neoplasm.